ENZN - Enzon Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
+0.0013 (+0.73%)
At close: 2:28PM EDT
Stock chart is not supported by your current browser
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
  • Short Term
    2W - 6W
  • Mid Term
    6W - 9M
  • Long Term
Previous Close0.1780
Bid0.3800 x 3000
Ask1.4100 x 200
Day's Range0.1721 - 0.1793
52 Week Range0.1400 - 0.3100
Avg. Volume54,300
Market Cap7.928M
Beta (5Y Monthly)0.26
PE Ratio (TTM)N/A
EPS (TTM)-0.0220
Earnings DateFeb 21, 2019
Forward Dividend & Yield0.12 (66.89%)
Ex-Dividend DateSep 30, 2019
1y Target Est14.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • We're sorry we weren't able to find anything about this topic.